Gyre Therapeutics, Inc. (GYRE) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
GYRE Stock Price Trajectory (2011–2026)
As of March 1, 2026, Gyre Therapeutics, Inc. (GYRE) trades at $8.24, representing a -29.0% return over the past year. The stock has delivered a -38.5% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $47,990.25 on March 1, 2011. From this peak, GYRE has corrected -100.0%, currently trading 4% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers ARGX (+22.8% 1Y), CANF (+169.9% 1Y), and AKTX (-72.9% 1Y), GYRE has underperformed the peer group average. Compare GYRE vs ARGX →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 8.47 | 8.65 | 8.22 | 8.24 | 8 | -3.29% |
| 2026-02-26 | 8.61 | 8.63 | 8.36 | 8.52 | 8 | -1.50% |
| 2026-02-25 | 8.50 | 8.95 | 8.50 | 8.65 | 8 | +2.98% |
| 2026-02-24 | 8.49 | 8.62 | 8.27 | 8.40 | 8 | +3.07% |
| 2026-02-23 | 8.60 | 8.60 | 8.07 | 8.15 | 8 | -1.57% |
| 2026-02-20 | 8.45 | 8.62 | 8.21 | 8.28 | 8 | -1.66% |
| 2026-02-19 | 8.20 | 8.49 | 8.20 | 8.42 | 60K | +2.56% |
| 2026-02-18 | 8.27 | 8.33 | 8.10 | 8.21 | 68K | +3.27% |
| 2026-02-17 | 7.90 | 8.10 | 7.90 | 7.95 | 3K | -0.87% |
| 2026-02-13 | 7.86 | 8.19 | 7.86 | 8.02 | 63K | +2.56% |
| 2026-02-12 | 7.83 | 7.91 | 7.60 | 7.82 | 38K | -0.38% |
| 2026-02-11 | 8.00 | 8.15 | 7.75 | 7.85 | 38K | -1.51% |
| 2026-02-10 | 7.75 | 8.07 | 7.73 | 7.97 | 58K | +1.92% |
| 2026-02-09 | 7.91 | 7.91 | 7.69 | 7.82 | 23K | -0.76% |
| 2026-02-06 | 7.64 | 7.90 | 7.58 | 7.88 | 48K | +4.93% |
| 2026-02-05 | 7.70 | 7.85 | 7.45 | 7.51 | 47K | -3.35% |
| 2026-02-04 | 7.84 | 7.92 | 7.60 | 7.77 | 46K | -1.89% |
| 2026-02-03 | 8.21 | 8.21 | 7.74 | 7.92 | 43K | -3.53% |
| 2026-02-02 | 8.00 | 8.28 | 7.98 | 8.21 | 133K | +1.48% |
| 2026-01-30 | 8.08 | 8.25 | 7.97 | 8.09 | 92K | -1.46% |
| 2026-01-29 | 8.07 | 8.25 | 7.84 | 8.21 | 100K | +2.24% |
| 2026-01-28 | 8.04 | 8.17 | 7.99 | 8.03 | 79K | -0.74% |
| 2026-01-27 | 7.89 | 8.09 | 7.78 | 8.09 | 54K | +2.41% |
| 2026-01-26 | 7.82 | 8.01 | 7.82 | 7.90 | 31K | +0.64% |
| 2026-01-24 | 8.04 | 8.04 | 7.72 | 7.85 | 65K | 0.00% |
| 2026-01-23 | 8.04 | 8.04 | 7.72 | 7.85 | 66K | -2.48% |
| 2026-01-22 | 8.23 | 8.38 | 8.00 | 8.05 | 67K | -3.01% |
| 2026-01-21 | 8.00 | 8.30 | 7.89 | 8.30 | 179K | +4.67% |
| 2026-01-20 | 7.62 | 8.00 | 7.53 | 7.93 | 75K | +3.26% |
| 2026-01-16 | 7.70 | 7.74 | 7.55 | 7.68 | 35K | -0.26% |
See GYRE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GYRE Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare GYRE vs AGIO
See how GYRE stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has GYRE stock performed recently?
GYRE declined -29.0% over the past year, below its 5-year annualized CAGR of -38.5%. The stock trades above its 200-day moving average, reflecting the downtrend.
What is GYRE's all-time high price?
Gyre Therapeutics, Inc. reached $47990.25 on 2011-03-01. The 52-week high is $13.75. Current 1-year return of -29.0% places the stock further from historical peaks.
Where can I download GYRE historical price data?
This page provides GYRE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.